IL7 and exocrine pancreatic carcinoma: Most recently, IL-7– and CCL21-expressing (7 × 21) CAR T cells were reported to yield better efficacy than 7 × 19 CAR T cells in mouse solid tumor models of pancreatic carcinoma, breast cancer, and HCC without preconditional lymphodepletion (34).